Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
Article links to spybiotech.com
March 20, 2023
SpyBiotech Receives Grant from the Bill & Melinda Gates Foundation
February 7, 2023
Our 2022 Highlights
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
All News
07•11•22
Portfolio News
Genomics
Genomics announces successful world-first pilot using improved genomic risk assessment in cardiovascular disease prevention in the NHS
09•10•22
Portfolio News
Genomics
Genomics announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
06•09•22
Portfolio News
Genomics
Genomics announces that Simon Dingemans has joined its board as the new chair
23•08•21
Portfolio News
Genomics
Genomics academic founder and CEO, Sir Peter Donnelly, awarded Royal Society Gabor medal
01•03•21
Portfolio News
Genomics
Genomics completes oversubscribed $30m funding round
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal